CN105503531A - 一种真菌培养物的提取物及其制备方法和应用 - Google Patents
一种真菌培养物的提取物及其制备方法和应用 Download PDFInfo
- Publication number
- CN105503531A CN105503531A CN201510884270.8A CN201510884270A CN105503531A CN 105503531 A CN105503531 A CN 105503531A CN 201510884270 A CN201510884270 A CN 201510884270A CN 105503531 A CN105503531 A CN 105503531A
- Authority
- CN
- China
- Prior art keywords
- extract
- preparation
- fungal cultures
- culture
- rice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 241000233866 Fungi Species 0.000 title claims abstract description 20
- 238000012136 culture method Methods 0.000 title 1
- 238000011218 seed culture Methods 0.000 claims abstract description 28
- 238000000605 extraction Methods 0.000 claims abstract description 17
- 208000024827 Alzheimer disease Diseases 0.000 claims abstract description 15
- 238000000855 fermentation Methods 0.000 claims abstract description 15
- 230000004151 fermentation Effects 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 33
- 150000001875 compounds Chemical class 0.000 claims description 31
- 241000209094 Oryza Species 0.000 claims description 24
- 235000007164 Oryza sativa Nutrition 0.000 claims description 24
- 235000009566 rice Nutrition 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 16
- 238000004362 fungal culture Methods 0.000 claims description 16
- 235000002639 sodium chloride Nutrition 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 16
- 239000012531 culture fluid Substances 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 14
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000001963 growth medium Substances 0.000 claims description 11
- 238000010898 silica gel chromatography Methods 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 230000002441 reversible effect Effects 0.000 claims description 10
- 238000004220 aggregation Methods 0.000 claims description 8
- 230000002776 aggregation Effects 0.000 claims description 7
- 239000012230 colorless oil Substances 0.000 claims description 7
- 238000000746 purification Methods 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000001888 Peptone Substances 0.000 claims description 4
- 108010080698 Peptones Proteins 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 239000002054 inoculum Substances 0.000 claims description 4
- 235000019319 peptone Nutrition 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- 235000014666 liquid concentrate Nutrition 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 6
- 239000002024 ethyl acetate extract Substances 0.000 abstract description 2
- 241001557886 Trichoderma sp. Species 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 230000006919 peptide aggregation Effects 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000002137 ultrasound extraction Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 229960001866 silicon dioxide Drugs 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 101100391174 Dictyostelium discoideum forC gene Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- CTTSYRDQSMAGNT-UHFFFAOYSA-N 3-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-1,2-dimethylcyclopentan-1-ol Chemical compound C1CC(O)(C)C(C)C1C1(C)OC(C(C)(C)O)CC1 CTTSYRDQSMAGNT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 238000005100 correlation spectroscopy Methods 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000004845 protein aggregation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- ZBJPVPFEDGYYBD-GBJTYRQASA-N (1r,2s,3r)-3-[(2r)-2-hydroxy-6-methylhept-5-en-2-yl]-1,2-dimethylcyclopentan-1-ol Chemical compound C[C@H]1[C@H]([C@](C)(O)CCC=C(C)C)CC[C@@]1(C)O ZBJPVPFEDGYYBD-GBJTYRQASA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 101800001718 Amyloid-beta protein Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 206010010254 Concussion Diseases 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- UGAPHEBNTGUMBB-UHFFFAOYSA-N acetic acid;ethyl acetate Chemical compound CC(O)=O.CCOC(C)=O UGAPHEBNTGUMBB-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000007131 anti Alzheimer effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- ZBJPVPFEDGYYBD-UHFFFAOYSA-N cyclonerodiol Natural products CC1C(C(C)(O)CCC=C(C)C)CCC1(C)O ZBJPVPFEDGYYBD-UHFFFAOYSA-N 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
- C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
- C07C35/06—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Position | δH(JinHz) | δC | 1H,1H-COSY | HMBC |
2 | 73.0 |
3 | 1.63,1H(m) | 54.2 | H-4,H-7 | C-2,C-4 |
4 | 1.62,1.45,2H(m) | 24.0 | H-3,H-5 | |
5 | 1.50,1.36,2H(m) | 39.9 | H-4 | |
6 | 79.1 | |||
7 | 1.47,1H(m) | 43.8 | H-3,H-8 | |
8 | 0.90,3H(d),J=6.8 | 15.1 | H-7 | C-3,C-6,C-7,C-9 |
9 | 1.10,3H(s) | 26.3 | C-5,C-6,C-7 | |
1’ | 1.59,1.20,2H(m) | 38.2 | H-2’ | |
2’ | 1.58,1.06,2H(m) | 25.4 | H-1’,H-3’ | C-1’,C-2 |
3’ | 3.00,1H(dt),J=5.2,6.4 | 78.5 | H-2’,OH-3’ | C-2’,C-4’ |
4’ | 71.7 | |||
5’ | 0.97,3H(s) | 24.8 | C-3’,C-4’,C-5’ | |
6’ | 1.03,3H(s) | 26.2 | C-3’,C-4’,C-5’ | |
7’ | 0.99,3H(s) | 24.8 | C-2,C-3,C-1’ | |
2-OH | 3.76,1H(br.s) | C-1’,C-2,C-7’ | ||
6-OH | 3.78,1H(br.s) | C-5,C-6,C-7,C-9 | ||
3’-OH | 4.20,1H(d),J=5.2 | C-2’,C-3’,C-4’ | ||
4’-OH | 4.01,1H(br.s) | C-3’,C-4’,C-5’,C-6’ |
样品 | 相对抑制活性(%)(100uM) |
EGCG | 72.02士1.56 |
式(Ⅰ)化合物 | 32.71士10.49 |
式(Ⅱ)化合物 | 56.69士8.08 |
式(Ⅲ)化合物 | 36.53士1.99 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510884270.8A CN105503531B (zh) | 2015-12-04 | 2015-12-04 | 一种真菌培养物的提取物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510884270.8A CN105503531B (zh) | 2015-12-04 | 2015-12-04 | 一种真菌培养物的提取物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105503531A true CN105503531A (zh) | 2016-04-20 |
CN105503531B CN105503531B (zh) | 2017-09-26 |
Family
ID=55711908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510884270.8A Active CN105503531B (zh) | 2015-12-04 | 2015-12-04 | 一种真菌培养物的提取物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105503531B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106497797A (zh) * | 2016-11-01 | 2017-03-15 | 深圳大学 | 一种真菌培养物的提取物及其制备方法和应用 |
CN106565639A (zh) * | 2016-10-14 | 2017-04-19 | 宁波大学 | 一种四氢呋喃类化合物及其制备方法和用途 |
CN106966887A (zh) * | 2017-03-28 | 2017-07-21 | 兰州理工大学 | 胶孢炭疽菌中分离的化合物及其制备方法与用途 |
CN107814688A (zh) * | 2017-11-16 | 2018-03-20 | 青岛农业大学 | 两种Cyclonerodiol类倍半萜衍生物及其制备方法和应用 |
CN108373457A (zh) * | 2018-04-23 | 2018-08-07 | 中国科学院烟台海岸带研究所 | 一种环氧倍半萜类化合物及其制备和应用 |
CN109400444A (zh) * | 2017-08-16 | 2019-03-01 | 兰州大学 | 抑制植物病源真菌的倍半萜类化合物及其制备方法 |
CN114410477A (zh) * | 2021-11-29 | 2022-04-29 | 深圳大学 | 一种诱导型no合成酶的抑制剂及其生产菌株和制备方法 |
-
2015
- 2015-12-04 CN CN201510884270.8A patent/CN105503531B/zh active Active
Non-Patent Citations (1)
Title |
---|
赵丹奇等: "海绵共附生真菌Hansfordia sp. 次级代谢产物的分离和鉴定", 《沈阳药科大学学报》 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106565639A (zh) * | 2016-10-14 | 2017-04-19 | 宁波大学 | 一种四氢呋喃类化合物及其制备方法和用途 |
CN106565639B (zh) * | 2016-10-14 | 2018-09-21 | 宁波大学 | 一种四氢呋喃类化合物及其制备方法和用途 |
CN106497797A (zh) * | 2016-11-01 | 2017-03-15 | 深圳大学 | 一种真菌培养物的提取物及其制备方法和应用 |
CN106966887A (zh) * | 2017-03-28 | 2017-07-21 | 兰州理工大学 | 胶孢炭疽菌中分离的化合物及其制备方法与用途 |
CN106966887B (zh) * | 2017-03-28 | 2020-06-05 | 兰州理工大学 | 胶孢炭疽菌中分离的化合物及其制备方法与用途 |
CN109400444A (zh) * | 2017-08-16 | 2019-03-01 | 兰州大学 | 抑制植物病源真菌的倍半萜类化合物及其制备方法 |
CN107814688A (zh) * | 2017-11-16 | 2018-03-20 | 青岛农业大学 | 两种Cyclonerodiol类倍半萜衍生物及其制备方法和应用 |
CN108373457A (zh) * | 2018-04-23 | 2018-08-07 | 中国科学院烟台海岸带研究所 | 一种环氧倍半萜类化合物及其制备和应用 |
CN108373457B (zh) * | 2018-04-23 | 2021-04-06 | 中国科学院烟台海岸带研究所 | 一种环氧倍半萜类化合物及其制备和应用 |
CN114410477A (zh) * | 2021-11-29 | 2022-04-29 | 深圳大学 | 一种诱导型no合成酶的抑制剂及其生产菌株和制备方法 |
CN114410477B (zh) * | 2021-11-29 | 2023-10-10 | 深圳大学 | 一种诱导型no合成酶的抑制剂及其生产菌株和制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105503531B (zh) | 2017-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105503531A (zh) | 一种真菌培养物的提取物及其制备方法和应用 | |
CN105198885B (zh) | 具有抗心律失调活性的化合物communesin I及其制备方法和用途 | |
CN108358946A (zh) | 一类蒽醌类化合物及其制备方法和在制备治疗癌症药物中的应用 | |
CN104877910A (zh) | 一种植物内生真菌布雷正青霉菌F4a及其应用 | |
CN101735236B (zh) | 二聚桔霉素类化合物及其制备方法和用途 | |
CN106432168B (zh) | 红树尖瓣海莲内生真菌来源的抗弧菌活性化合物及其制备方法 | |
CN103655215A (zh) | 具有抑制酪氨酸酶活性和清除自由基活性的拟青霉提取物及其用途 | |
CN103494844B (zh) | 黄蘑菇标准化组分制法及其在肝癌治疗中的应用 | |
CN103351281B (zh) | 一类海洋来源的二倍半萜类化合物及其制备方法和应用 | |
CN106434361B (zh) | 一类海洋真菌来源的茚酮衍生物及其制备方法和应用 | |
CN106967024A (zh) | 一种α‑吡喃酮衍生物及其制备方法和应用 | |
CN107686816A (zh) | 一种鼠妇共生菌球毛壳霉及其在制备抗肿瘤化合物中的应用 | |
CN106117232A (zh) | 一类新型的细菌群体感应抑制剂及其抗菌应用 | |
CN103880826B (zh) | 一种异苯并呋喃酮化合物及其制备方法和应用 | |
CN108342325B (zh) | 一种蝉虫草来源的蒽醌类化合物及其制备方法和应用 | |
CN109081842B (zh) | 一种深海真菌来源蒽醌类化合物及其在制备抗过敏药物中的应用 | |
CN103014090A (zh) | 一种从莫勒菌中提取双苯恶庚因-11(6h)酮-1,10-二羟基,3 -甲基-7,8-二甲氧的方法 | |
CN107226800A (zh) | 一种xanthone类化合物及其单晶的制备方法与作为抗海分枝杆菌药物的应用 | |
KR900004437B1 (ko) | 식물배양에 있어서의 2차 대사산물 생산의 유도방법 및 그 수단 | |
CN102452916B (zh) | 一类芳香聚酮及其提取方法和应用 | |
CN110368389A (zh) | 酚类化合物的制备方法及其应用和抗过敏药物 | |
CN105030790B (zh) | 人参二醇衍生物在制备预防或治疗肝病药物中的应用 | |
CN104450818B (zh) | 一种利用羊肚菌制备吡咯酸化合物的方法及其应用 | |
CN101735237B (zh) | 三聚桔霉素类化合物及其制备方法和用途 | |
CN108070626A (zh) | 一种从亚肉座菌中提取6,8-二羟基-3-羟甲基异香豆素的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160420 Assignee: SHENZHEN SENYING BIO-TECH CO.,LTD. Assignor: SHENZHEN University Contract record no.: X2022980023878 Denomination of invention: Extract of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20221130 Application publication date: 20160420 Assignee: Foshan Yitong Intelligent Technology Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2022980024278 Denomination of invention: Extract of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20221201 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160420 Assignee: Shenzhen Dongfang Renshou Life Technology Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2022980025926 Denomination of invention: Extract of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20221211 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160420 Assignee: Shuotai New Materials (Shenzhen) Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2023980034041 Denomination of invention: Extract of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20230324 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160420 Assignee: Shenzhen kangruihua Medical Technology Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2023980045648 Denomination of invention: Extract of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20231103 Application publication date: 20160420 Assignee: Shenzhen Ruikanghua Medical Technology Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2023980045608 Denomination of invention: Extract of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20231103 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160420 Assignee: Shenzhen Ruisheng Bioengineering Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2023980047944 Denomination of invention: Extraction of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20231123 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160420 Assignee: Guangdong Whale Biotechnology Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2023980048812 Denomination of invention: Extraction of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20231129 Application publication date: 20160420 Assignee: Guangdong Bonn Life Sciences Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2023980048412 Denomination of invention: Extraction of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20231127 Application publication date: 20160420 Assignee: SHENZHEN YUPENG TECHNOLOGY Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2023980048359 Denomination of invention: Extraction of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20231127 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160420 Assignee: Shenzhen Zhongke Tuoda Technology Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2023980050488 Denomination of invention: Extraction of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20231208 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160420 Assignee: Tomorrow Star Pharmaceutical Biotechnology Research and Development (Zhaoqing City) Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2024980003680 Denomination of invention: Extraction of a fungal culture and its preparation method and application Granted publication date: 20170926 License type: Common License Record date: 20240329 |
|
EE01 | Entry into force of recordation of patent licensing contract |